Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

How to Prepare Project Report on Pharmaceutical Processing Industry?

Drug manufacturing companies work under strict laws and regulations. Their processes need to comply with relevant drugs act in their respective countries.

Therefore, if you are planning to invest in pharmaceutical processing, a good project report will be necessary. Besides the prominent aspects of a project report, you should pay close attention to the following issues in a pharmaceutical processing report.

1. Marketing

This industry is very competitive. I need not stress the value of detailed market analysis. You need to understand the status of market competition and the demand for pharmaceutical products. A proper market analysis will additionally help you prepare an excellent pharmaceutical business plan. Given your market analysis report, you will develop a marketing plan.

2. Government approval

In almost all countries, there are laws and regulations for the manufacture, distribution, and administration of drugs. Consider giving a status report on these requirements when making the final project status report.

3. Manufacturing Process

It would help if you had a picture of the process you will employ in making your drugs. Outline the quality checks and balances in the process. State the required pharmaceutical intermediates and their corresponding active pharmaceutical ingredients.

4. Machines and Equipment

You need to identify the equipment you will need, such as homogenizers, spectrophotometer, tabulating machines, etc. to ensure the machines meet quality specifications. You may also need to put down a plan to train workers on their operations.

How Does the Drug Manufacturing Process Work?

If you are an aspiring drug manufacturer, you should know how the bulk drug manufacturing process works. This is a complicated process and requires professional skills in molecular biology, medical microbiology, and pharmacy.

The process involves four steps, namely:

  • Milling
  • Granulation
  • Coating
  • Tabulation

Milling is important because it makes the drug powder uniform. It ensures uniform distribution of the active pharmaceutical ingredients. Additionally, milling makes it easier to formulate the drug into a syrup or emulsion.

After milling, you can use wet or dry granulation to form granules. You then coat them and compress the drugs using a tabulating machine. Alternatively, you can fill the granules into capsules.

For any chemical industry business ideas, prioritize the security of your staff. Ensure workers have sufficient PPEs. Have plans to protect them from chemical poisoning. Install eyewashes and emergency showers in both production units and laboratories.

Pre-Feasibility Report on Bulk Drug Manufacturing Process

Before you set up a feasibility report or start making a business plan, you first need to do a pre-feasibility study. It is the conclusions of this study that will make you decide whether to proceed to the project feasibility report or not.

Implementing a pharmacy business plan is an expensive affair. Please do not put any investment into a business plan of this magnitude without looking at its feasibility study report.

Considering the variety of pharmaceutical products, a feasibility plan will help you decide on the most relevant product for your target market. The results of pre-feasibility and feasibility studies will inform your marketing strategy plan. At the pre-feasibility stage, you get to review the technical skills required for the bulk drug manufacturing process. You also assess the knowledge level and determine whether you have the knowledge and skills.

Lastly, this report looks at the financial demands of a chemical project report on bulk drug processing. From here, you will decide on the feasibility of the project.

How to Grow Pharmaceutical Intermediates Market?

The pharmaceutical industry relies on pharmaceutical intermediates. We use these chemicals to produce active pharmaceutical ingredients (API). 

To grow the pharmaceutical intermediates market, therefore, we should focus on the drug manufacturing industry. Here are some tips on how we can grow this industry.

1. Investment in Research and Development

We should encourage governments and established drug manufacturers to invest in research and development of new medicines. New drug development will increase the need for pharmaceutical intermediates. Consequently, this will cause the growth of the industry.

2. Boost Generic Drug Manufacturing

Feasibility study reports for project ideas in pharmaceuticals show a growing demand for generics. This demand is particularly high in developing countries. More investment in generic drugs will result in increased demand for pharmaceutical intermediates.

3. Collaborations

It is quite expensive to run a pharmaceutical intermediate processing company. If you look at a project summary example for the local industry and you will notice the huge investment. One way of cushioning the industry is to encourage collaborations, mergers, and acquisitions. Working together gives small-scale companies a competitive advantage. It lowers their operation costs and improves revenue.

How to Set Up a Chemical Industry Business Plan?

Writing a chemical industry business plan begins with a pre-feasibility study. Here, you look at the various business ideas in chemical manufacturing. You then evaluate each of these ideas based on:

1. Skills and Knowledge

If you are interested in the chemical manufacturing industry, I assume that you have some skills or knowledge in this sector. If so, look at the skills required for each idea you have. Which of these ideas marches your skills and knowledge?

2. Financial Resources

Different chemical processes have different cost implications. Try to review each idea against the expected financial input. You can examine some business plan examples on the internet to get a hint on required inputs. Once you have a convincing pre-feasibility report, you can proceed to make a feasibility report meaning the idea is profitable and viable.

The next step in setting up a chemical industry business plan is to prepare a small business marketing plan. The results of your feasibility report will help do this.

Chemical manufacturing is not only expensive, but it is also strictly regulated by law. It would be best if you had an innovative marketing strategy to break even. It would be best if you did an accurate market analysis.

A project report on the pharmaceutical industry helps you assess the dynamics of the industry. You will want to know who the major chemical manufacturers are. You will also assess the availability of raw materials and machinery for your pharmaceutical industry.

In your project report, you will also address the technical aspects of the pharmaceutical manufacturing process. You need to draw a flow diagram for the process. Lastly, sit down and draw a business plan for your chemical industry business. You will need the information from all the above processes. Additionally, a business plan will consider the financial implications of your pharmaceutical industry project report.


We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 23 of 24 | Total 236 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 23 24   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient. Investment Opportunity for Startups and Entrepreneurs. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. Ciprofloxacin is FDA approved for the treatment of urinary tract infections, sexually transmitted infections (gonorrhea and cancroid), skin, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Uses and Applications Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Mycoplasma contamination is a major problem in cell culture in biomedical and biopharmaceutical research, with rates near 15-30%. While there is no method for visual confirmation of mycoplasma, contamination has serious effects on key characteristics and functions of cells, thus compromising any research done. Cipro (ciprofloxacin hydrochloride) is the standard antibiotic for rapid and efficient decontamination. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks CIPRO is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis. Ciprofloxacin (Cetraxal, Ciloxan, and Cipro) is an inexpensive drug used to treat certain bacterial infections. It is more popular than comparable drugs. Application Urogenital Infections Respiratory Tract Infections Gastrointestinal Infections Typhoid Bone and Joint Infections Skin and Soft Tissue Infections Sepsis and Other Systemic Infections Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Government Initiatives • Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: • India plans to set up a nearly Rs 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023. • In November 2019, the Cabinet approved extension/renewal of extant Pharmaceuticals Purchase Policy (PPP) with the same terms and conditions while adding one additional product namely, Alcoholic Hand Disinfectant (AHD) to the existing list of 103 medicines till the final closure/strategic disinvestment of Pharma CPSUs. • Under Budget 2020-21, Rs 65,012 crore (US$ 9.30 billion) has been allocated to the Ministry of Health and Family Welfare is. The Government has allocated Rs 34,115 crore (US$ 4.88 billion) towards the National Health Mission under which rural and urban people will get benefited. • Rs 6,400 crore (US$ 915.72 million) has been allocated to health insurance scheme Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). • As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 per cent in FY20 from 1.2 per cent in FY15 on health. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates • The National Health Protection Scheme is the largest Government funded healthcare programme in the world, which is expected to benefit 100 million poor families in the country by providing a cover of up to Rs 5 lakh (US$ 7,723.2) per family per year for secondary and tertiary care hospitalisation. The programme was announced in Union Budget 2018-19. • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy to stop any misuse due to easy availability. • Government of India unveiled 'Pharma Vision 2020' to make India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investment. • India has imposed a provisional anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China on the grounds that it was hurting domestic industry, following an investigation of the Directorate General of Trade Remedies (DGTR). • The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. • Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections and certain types of diarrhea. The DGTR had initiated the investigation in January this year. Related Videos: - Industrial, Medical and Specialty Gases Manufacturing Project Ideas Market Outlook The India ciprofloxacin market is segmented based on composition, source, and form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, optic, and intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability. The Global Ciprofloxacin Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027. Related Project:- Ciprofloxacin Hydrochloride Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. The remaining of the active pharmaceutical ingredient of ciprofloxacin is being dispersed in another combination product and specifically utilize in the urinary tract antibiotic only. Thereby anticipated to lure the new market players in the ciprofloxacin market. The higher incidence of skin and immunological disorder is anticipated to offer a steady revenue generation opportunity in the ciprofloxacin market. Increase awareness about safe drug utilization, however increase in adverse drug reaction awareness and stringent government impositions have narrowed the growth path for global Ciprofloxacin market in North America. Furthermore in East Asia region considerably higher market growth rate is expected due to higher utilization of ciprofloxacin in renal infection in the region. Thereby anticipated to increase the revenue generation in the Ciprofloxacin market. Related Projects: - Chemicals (Organic, Inorganic, Industrial) Projects The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. Related Projects: - Active Pharma Ingredients(API) Key Players:- ? Aarti Drugs Ltd. ? Aurobindo Pharma Ltd. ? Cipla Ltd. ? Indoco Remedies Ltd. ? Kores (India) Ltd. ? Mylan Pharmaceuticals Pvt. Ltd. ? Neuland Laboratories Ltd. ? S S Organics Ltd ? Smruthi Organics Ltd. ? Sreepathi Pharmaceuticals Ltd. ? Sterling Basic Organics Ltd. ? Sun Pharma Laboratories Ltd. ? Sun Pharma Medisales Pvt. Ltd. ? Wockhardt Ltd. Tags:- #CiprofloxacinHydrochloride #Ciprofloxacin #CiprofloxacinBusinessPlan #activepharmaceuticalingrediants #activepharmaingredient #Pharmaceutical #pharmaindustry #APIManufacturing #APIProduction #APImarket #APIBusiness #APIbusinessplan #startupAPIbusiness #CIPRO #startyourbusiness #investmentopportunity #covidbusiness #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #ChemicalIndustry
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufacture packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Abaris Healthcare Pvt. Ltd. Axa Parenterals Ltd. Infutec Healthcare Ltd. Parenteral Surgicals Ltd Pharmazell (India) Pvt. Ltd. Shree Krishna Keshav Laboratories Ltd. Punjab Formulations Ltd.
Plant capacity: IV Fluids (500 ml Size Bottle) :100,000 Bottles / DayPlant & machinery: Rs 751 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1277 lakhs
Return: 26.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Manufacturing of 7-Aminocephalosporanic Acid (7-ACA)

Manufacturing of 7-Aminocephalosporanic Acid (7-ACA) – Active Pharma Ingredient (API). Profit-Making Industry for Startups. 7-aminocephalosporanic acid is abbreviated as 7-ACA, white or almost white crystalline powder, 7-ACA is an important nucleus in synthesis of cephalosporin antibiotics, in the nucleus 7 and 3 chemical transformation can be used to prepare many cephalosporin’s: cefazolin sodium , cefotaxime sodium, ceftriaxone sodium, Cefoperazone sodium, sodium ceftazidime, cefuroxime sodium. Cephalosporin antibiotics (Cephalosporin) are a cluster of broad-spectrum semisynthetic antibiotics, they all contain the nucleus of 7-aminocephalosporanic acid (7-ACA), with different groups in the 3 and 7 carbon atoms, forming various cephalosporin with different antibacterial activity and pharmacokinetic characteristics. Cephalosporin antibiotics have broad antibacterial spectrum, strong antibacterial effect, and fewer allergic reactions, and only part of the cross allergic with penicillin and they have varying degrees of stability on the ?-lactamase. Cephalosporin have fast development, and many families, they are divided into four generation cephalosporin according to the anti-microbial dynamic. Related Project: - 7-aminocephalosporanic Acid (7-aca) Strength of APIs Manufacturers use certain standards to determine how strong the API is in each drug. However, the standard can vary widely from one brand to another. Each brand might use different test methods that can result in different potencies. In all cases, manufacturers are required by the FDA to prove the potency of their products in real-life patients, as well as in laboratory conditions. Related Projects:- Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Market Outlook The Global 7-Aminocephalosporanic Acid (7-ACA) Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026. The increasing prevalence of congenital heart disease acts as a growth driver for the overall market. Epidemiological studies have shown how lifestyle habits such as smoking and dietary irregularities-which can result in obesity-are associated with increased risk of disease. Increasing prevalence of obesity is hence estimated to drive the demand for APIs. Related Books:- Pharmaceutical, Drugs, Proteins Technology Handbooks The active pharmaceutical ingredients share price has risen incrementally over the past few years due to medicinal properties. The drugs taken together with combined therapy have numerous active ingredients to treat a range of disorders. The various types of active pharmaceutical ingredients are prime elements in the production of drugs, and this global market is estimated to experience optimistic growth in the upcoming period. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. Market Research:- Market Research Report The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Projects:- Project Reports & Profiles Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Related Project:- 7-aminocephalosporanic Acid (7-aca) Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Projects:- Project Reports & Profiles Tags;- #7AminocephalosporanicAcid #7ACA #7ACAProduction #7ACAMarket #Pharmaceutical #pharmaindustry #activepharmaceuticalingredientimport #activepharmaceuticalingrediants #activepharmaingredient #APIMarket #APIManufacturing #pharmaceuticalmanufacturing #ActivePharmaceuiticalIngredientsmarket #7AminocephalosporanicAcidBusinessPlan #APIbulkdrug #DetailedProjectReport #businessconsultant #feasibilityReport #NPCS #entrepreneurindia #startupbusiness #BusinessPlan #InvestInStartups #StartupIdea #startupinvestment #StartupBusinessPlan #StartupPlan #NewRelease #startupinvestment #startup #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #InvestInStartups #StartupIndiaConsultants #Plan4Business #StartupPlan #InvestingCapitalForBusiness #HowToMakeYourBusinessMoreSuccessful #investorbusiness #Startupcapital #BusinessPlanning #TechnologyTrendsForBusiness #StartupIdea
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Manufacturing of DCDA - Dicyandiamide (2-Cyanoguanidine).

Manufacturing of DCDA - Dicyandiamide (2-Cyanoguanidine). Active Pharma Ingredient (API). Profit-Making Industry for Startups in Pharmaceutical. Dicyandiamide is often used as a curing agent for epoxies and as a used as a stabilizer compound for PVC flooring. Another popular use of Dycyandiamide (DICY) is a flame retardant additive in the paper and textile industries. Dicyandiamide can be used as a slow release fertilizer. Dycandiamide also finds applications in the adhesive industry, powder coatings, dielectric coatings, water treatment chemicals, rubber, dye fixing, and pharmaceutical applications. Related Project: - Dicyandiamide (dcda) Application Dicyandiamide is used as a slow release fertilizer. In the adhesive industry, Dicyandiamide is used as a curing agent for epoxies. Dicyandiamide is also used as a flame retardant additive in paper and textile industries. Additional applications include use in powder coatings, dielectric coatings, water treatment chemicals, rubber, dye fixing, and pharmaceutical applications. Dicyandiamide is also used as a stabilizer compound for PVC flooring. Projects: - Project Reports & Profiles Uses:- Adhesive-General adhesives and binding agents for a variety of uses Agricultural-Relating to agricultural, including the raising and farming of animals and growing of crops Building_material, insulation-Insulating materials to protect from noise, cold, etc (such as used in homes or buildings), insulating materials related to electricity. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Colorant-Term used for colorants, dyes, or pigments; includes colorants for drugs, textiles, personal care products (cosmetics, tatoo inks, hair dye), food colorants, and inks for printing; modifiers included when application is known Construction-General construction (as opposed to those things labeled building construction) Market Outlook Dicyandiamide Market size should observe lucrative CAGR from 2019 to 2025 in the coming years due to developments in the water treatment industry. Dicyandiamide or cyan guanidine is a free-flowing white colored versatile chemical with diverse applications. Extensive use of the product in wastewater treatment plants as a decoloring agent or flocculating agent will drive the market in coming years. Growth in wastewater treatment industry in the European countries will have significant impact on the dicyandiamide market. Related Projects: - Business Ideas after the Covid Breakdown The region has more than 18,000 wastewater treatment plants in operation. As the region’s major focus is sustainable development and to promote environment friendly products & techniques, the demand for dicyandiamide will rise in future. Moreover, the rising scarcity of clean water will lead to increasing water treatment facilities in emerging nations which will further boost the demand in the market. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks The factors that are playing a major role in the growth of dicyandiamide market are the growing number of diabetes patients, non-hazardous and extremely reactive, and the high demand from the end-users. However, the availability of alternative substitutes may restrain overall market growth in the years to come. Dicyandiamide market is segmented based on grade, distribution channel, application, and region. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs Global Dicyandiamide Market: Segmentation The global dicyandiamide market can be divided based on grade and application. On the basis of grade, the market is segmented into pharmaceutical, electronic, and industrial segments. Based on the application, the dicyandiamide market is divided into pharmaceuticals, epoxy laminates, slow-release fertilizers, flame retardants, dye fixing, and water treatment sectors. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates Key Players:- Helm India Pvt. Ltd. Lok Chemicals Pvt. Ltd. Prakash Chemicals Agencies Pvt. Ltd. Sanjay Chemicals (India) Pvt. Ltd. Unicare Pharma Ltd. Books: - BOOKS & DATABASES Tags:- #Dicyandiamide #DicyandiamideBusinessPlan #DicyandiamideManufacturing #DicyandiamideProduction #DicyandiamideInvestment #DicyandiamideMarket #DicyandiamideBusienss #apimanufacturing #pharmaceuticalindustry #chemicalindustry #pharmaceuticalmanufacturing #ActivePharmaceuticalIngredient #api #activepharmaceuticalingredient #pharmaceutical #ActivepharmaceuticalingredientMarket #ActivePharmaceutical #DCDAmanufacturing #DCDA #DetailedProjectReport #businessconsultant #feasibilityReport #NPCS #BusinessPlan #startup #InvestInStartups #entrepreneurindia #businessconsultant #StartupIdeas #NewRelease
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Glucose Saline

Glucose, also known as dextrose, is a simple sugar that can be found in nature and are chemically identical. Dextrose may decrease body protein and nitrogen losses, promote glycogen deposition, and decrease or prevent ketosis if sufficient doses are given. Since dextrose is usually metabolized to carbon dioxide and water, administration of a solution of dextrose and water is equivalent to providing the same volume of free water. Dextrose is readily metabolized; it increases blood glucose concentrations and provides calories. Dextrose may decrease body protein and nitrogen losses, promote glycogen deposition, and decrease or prevent ketosis if sufficient doses are given. Since dextrose is usually metabolized to carbon dioxide and water, administration of a solution of dextrose and water is equivalent to providing the same volume of free water. Following oral administration, dextrose, a monosaccharide, is rapidly absorbed from the small intestine principally by an active mechanism. It used for balancing the body fluid and it is added to the human body to balance the body fluid by injection which will recover fatality of the human being and recover the inside body pressure. Treatment of discarded water and electrolyte metabolism, especially in severe cases. Therapy of acid base in balances. The volume substitution and volume replacement in surgery of accident victim suffering blood lose. Arenteral nutrition for severally ill and post-operative patients. Saline is also often used for nasal washes to relieve some of the symptoms of the common cold. The solution exerts a softening and loosening influence on the mucus to make it easier to wash out and clear the nasal passages for both babies and adults. In this case "home-made" saline may be used: this is made by dissolving approximately half a teaspoon of table salt into 8 ounces (approx. 240ml) of clean tap water. The global intravenous solutions market reached a value of US$ 8.5 Billion in 2019. IV solutions and electrolytes are mainly used for fluid resuscitation, routine maintenance, replacement, and redistribution. The Market size value in 2020 is USD 86.2 million and Revenue forecast in 2025 is USD 121.7 million is expected to exhibit a CAGR of 7.1% from 2018 to 2025. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players • Amanta Healthcare Ltd. • Baxter Pharmaceuticals India Pvt. Ltd. • Bayer Pharmaceuticals Pvt. Ltd. • Denis Chem Lab Ltd. • Meridian Enterprises Pvt. Ltd. • Pfizer Healthcare India Pvt. Ltd. • Pfizer Ltd. • Pharmacia Healthcare Ltd. • Shree Krishna Keshav Laboratories Ltd. • Vikrant Pharmaceuticals Ltd.
Plant capacity: 200000 Bottles/ dayPlant & machinery: Rs. 2170 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 4083 Lakhs
Return: 25.00%Break even: 37.00%
Add to Inquiry Add to Inquiry Basket

Vitamin ‘C’ from Sorbitol

Vitamin c is chemically the simplest of the vitamins and for this reason was among the first to be isolated, characterized, and purified and to have its structure determined. More vitamin C is produced industrially than any other vitamin, or indeed all the other vitamins put together. Vitamin C has itself been said to have almost magical properties and it is useful to get a picture of the chemistry and biochemistry of this enigmatic compound. This has unearthed a rich vein of chemistry involving L-ascorbic acid as both a redox companion and as a complexion agent; indeed the reaction of L-ascorbic acid with oxygen and other oxidizing agents is catalyzed by transition metal ions, especially copper (II), so that sometimes solution are stabilized by the addition of EDTA, which complexes the metal ions and arrests the catalysis. It is one of the few pure chemical compounds which is taken routinely by human beings in gram quantities (a possible challenger is sugar). It appears to have no harmful effects even in these large amounts and it is a medicine which it is a pleasure to take, especially in the form of fruit or vegetables. Its role (as a constituent of fruits and vegetables) in the cure and prevention of scurvy was widely debated for hundreds of years. Ascorbic acid is generally used in bread due to its properties that help extend shelf life, high profile industrial bakers such as Hovis and Kings mill both use ascorbic acid in the majority of their loaves. Using ascorbic acid in an industrial bakery can contribute to higher profit yields, lower production times and higher buyer satisfaction longer shelf life, reduced number of damaged loaves during transport. The global Ascorbic Acid market is expected to witness moderate growth over the forecast period on account of increasing demand from pharmaceutical industry. The majority of ascorbic acid manufactured is used as an antioxidant. The major end-user industries of ascorbic acid are pharmaceuticals, food & beverages, personal care, and others. The pharmaceutical industry is the largest consumer of ascorbic acid. Vitamin C helps to recycle vitamin E. The presence of a broad distribution network of companies in this region will boost the Asia Pacific vitamin ingredients market in the near future. Analysts predict this regional market to rise at a CAGR of 5.40% from 2017 to 2025 in terms of value. Entrepreneurs who invest in this project will be successful. Few Indian major players • Dishman Pharmaceuticals & Chemicals Ltd. • Glaxosmithkline Pharmaceuticals Ltd. • Gulshan Polyols Ltd. • Kasyap Sweetners Ltd. • M S Healthcare Pvt. Ltd. • Pfizer Healthcare India Pvt. Ltd. • Pfizer Ltd. • Procter & Gamble Health Ltd. • Unicorn Organics Ltd.
Plant capacity: 600 kg/dayPlant & machinery: Rs. 371 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 717 Lakhs
Return: 24.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Business Ideas and Opportunities in Manufacturing of Vitamin C (Ascorbic Acid). Opportunities in Pharmaceutical Sector.

Introduction Vitamin C (ascorbic acid) is the most abundant natural hydro-soluble antioxidant used as a dietary supplement for humans. It can be contained in a number of fruits and vegetables, including lemons, oranges, and broccoli. It is also a critical cofactor for a number of metalloenzymes in the human body. Furthermore, because of its antioxidant properties, ascorbic acid is needed by the agriculture, food, beverage, and pharmaceutical industries. The pharmaceutical industry is the largest user of ascorbic acid, accounting for one-third of total production. Related Project:- Investment Business Idea in Vitamin C Manufacturing Plant Uses of vitamin C Because of its antioxidative properties, industrially generated L-ascorbic acid is commonly used as a dietary supplement and preservative in the feed, food, and pharmaceutical industries. Vitamin C is an essential nutrient for the human body. It is needed to keep the skin, cartilage, teeth, bone, and blood vessels healthy. It's also used to keep your body's cells protected from injury. It's referred to as an ant. It is now commonly promoted as a natural cure to the common cold. Despite its popularity as an "immune booster," there is no evidence that taking vitamin C will actually prevent or treat infection. Related Books:- Pharmaceutical, Drugs, Proteins Technology Handbooks Production process of vitamin C Additional bio-oxidation steps with Ketogulonicigenium vulgare as a biocatalyst are used in the production process to transform d-sorbitol to the intermediate 2KGA without the use of chemicals. The enzymes involved have a wide substrate variety but exhibit remarkable regiospecificity. The preferences of these enzymes for some of the many isomeric structures that carbohydrate substrates follow in aqueous solution explain this perplexing specificity pattern. Novel enzymes have recently been discovered that produce l-ascorbic acid directly from L-sorbosone, an intermediate in the bio-oxidation of d-sorbitol to 2KGA. This removes the need for 2KGA chemical rearrangement and allows for a direct route from d-sorbitol to l-ascorbic acid. The development of d-isoascorbic acid, the C5 epimer of l-ascorbic acid, follows similar industrial principles. D-isoascorbic acid has the same C5 conformation as d-glucose and can be made more easily from this common carb than l-ascorbic acid. Related Videos:- Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Market Outlook The strong application spectrum in the cosmetics, pharmaceutical, animal feed, and processed food industries is driving the market size of vitamin C. It's primarily found in fruits and vegetables, and it's also taken as a dietary supplement. It's used to avoid heart failure, vision disorders, immune system defects, skin wrinkling, and prenatal health problems. By 2024, the global vitamin market could be worth more than USD 10 billion. Vitamin C is a natural antioxidant that protects cells from free radical damage when they are exposed to radiation or UV rays. It is involved in protein metabolism and is needed for collagen biosynthesis. During the period 2020-2025, the ascorbic acid market is expected to develop at a CAGR of 5.1 percent. Books: - BOOKS & DATABASES Indian Govt Initiative for Vitamin C Production In the wake of domestic producers arguing for the implementation of a levy, India has launched an anti-dumping inquiry into vitamin C imports from China. The move comes days after the Directorate General of Trade Remedies (DGTR) of the Commerce Ministry placed a six-month provisional anti-dumping duty on anti-bacterial medication Ciprofloxacin Hydrochloride imports from China. The investigation has been launched after Bajaj Healthcare said that ‘dumped imports' of vitamin C from China are harming the domestic industry. Market Research; - Market Research Report “In terms of important product characteristics such as physical and chemical characteristics, manufacturing process and technology, functions and uses, product requirements, pricing, and distribution, subject products manufactured by domestic industry and PUC (product under consideration) imported from subject country (China) are comparable. The products' marketing and tariff classification,” the company had said. Key Players:- • Dishman Pharmaceuticals & Chemicals Ltd. • Glaxosmithkline Pharmaceuticals Ltd. • Gulshan Polyols Ltd. • Kasyap Sweetners Ltd. • M S Healthcare Pvt. Ltd. • Pfizer Healthcare India Pvt. Ltd. • Pfizer Ltd. For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/Production%20of%20Vitamin%20C%20(Ascorbic%20Acid)
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Business & Investment Opportunity in Manufacturing of Glucose Saline. IV fluids Used in Hospitals, Nursing Homes

Introduction: IV fluids are almost universally administered to patients undergoing major operations, where they meet the need to retain intravascular volume at a time when it may be exhausted due to preoperative fasting, surgical blood loss, evaporation, urinary excretion, Anesthesia-induced vasodilation, fluid loss into the third room, and inflammatory mediator-induced albumin transcapillary leak Water, sugar, and salt are all essential for the body to work properly. Intravenous fluids (also known as 'IV' fluids) are liquids that are supplied to replace water, sugar, and salt that you may need if you are sick or undergoing surgery and are unable to eat or drink. IV fluids are injected directly into a vein with a drip. Related Project: GLUCOSE SALINE Intravenous therapy (also known as IV therapy) is a surgical procedure that involves injecting fluids, drugs, and nutrients into a patient's vein. Intravenous administration is widely used to rehydrate or provide nutrients to those who are unable to absorb food or water through their mouth. Since drugs and fluid replacement are delivered directly into the circulatory system and therefore easily spread, the intravenous route is the quickest way to administer them in the body. As a result, intravenous administration is often used for the administration of certain recreational drugs. Many therapies are given as a "bolus," or one-time injection, but they can also be given as an infusion or drip over time. Intravenous treatment administration or the placement of an intravenous line ("IV line") for later use is a technique that can only be done by a trained physician. Uses of Glucose Saline: In clinical medicine, intravenous solutions are often used to replace and maintain body fluids. In general, intravenous fluids are used as I.V drips for patients in nursing homes and hospitals that are dehydrated or have severe disabling conditions. Related Videos: Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The body fluids are replanished with these intravenous fluids. Intravenous fluids (often abbreviated as 'IV' fluids) are liquids provided to replace water, sugar, and salt that you may need if you are sick or undergoing surgery and are unable to eat or drink normally. IV fluids are injected directly into a vein with a drip. IV rehydration was once a common method for athletes. Unless there is a medical exception, the World Anti-Doping Agency bans intravenous injections of more than 100mL every 12 hours. In addition to the risks associated with IV treatment, the US Anti-Doping Agency notes that "IVs can be used to change blood test outcomes." Related Books: Pharmaceutical, Drugs, Proteins Technology Handbooks Cover urine test results (by dilution) or administer banned substances in a way that would be removed from the body more easily in order to beat an anti-doping test (such as hematocrit when EPO or blood doping is used). Market Outlook: There are many varieties of intravenous solutions on the market, including isotonic, hypertonic, and hypotonic. Isotonic solutions are made up of normal saline (0.9 NaCl) and are used to substitute extracellular fluid in the treatment of hypernatremia. As electrolyte replenishers, hypotonic intravenous solutions of 0.45 percent NaCl are used. Increased prevalence of chronic and acute diseases, rise in the geriatric population, increase in strategic alliances between manufacturers to expand their product range and geographical presence, expansion in the pharmaceutical industry are all major drivers of the global intravenous solutions market. Market Research: - Market Research Report A rise in the demand for intravenous solutions in developed economies, as well as an increase in health-care spending however, the global intravenous solution market is expected to be restrained by factors such as a strict regulatory environment and high fluid maintenance costs. In the global economy, the intravenous (IV) solution market was rapidly growing and achieving a high market value. Intravenous solutions industry developments are supplying a variety of intravenous solutions to meet the needs of various types of patients. Key Players: • Amanta Healthcare Ltd. • Baxter Pharmaceuticals India Pvt. Ltd. • Bayer Pharmaceuticals Pvt. Ltd. • Denis Chem Lab Ltd. • Meridian Enterprises Pvt. Ltd. • Pfizer Healthcare India Pvt. Ltd. • Pfizer Ltd. • Pharmacia Healthcare Ltd. • Shree Krishna Keshav Laboratories Ltd. • Vikrant Pharmaceuticals Ltd. • Wockhardt Health Care Ltd. For More Details: - https://www.entrepreneurindia.co/project-and-profile-details/Business%20Plan%20of%20Glucose%20Saline%20Manufacturing
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Dextrose Saline

Normal saline (NS or N/S) is the commonly used phrase for a solution of 0.90% w/v of NaCl, about 300 mOsm/L or 9.0 g per liter. Aless commonly, this solution is referred to as physiological saline or isotonic saline, neither of which is technically accurate. NS is used frequently in intravenous drips (IVs) for patients who cannot take fluids orally and have developed or are in danger of developing dehydration or hypovolemia. For medical purposes, saline is often used to flush wounds and skin abrasions. Normal saline will not burn or sting when applied. Saline is also used in I.V. therapy, intraveno supplying extra water to rehydrate patients or supplying the daily water and salt needs ("maintenance" needs) of a patient who is unable to take them by mouth. Dextrose (D-glucose, corn sugar, starch sugar, blood sugar and grape sugar) is by far the most abundant sugar in nature and occurs either in the Free State (monosaccharide form) or chemically linked with other sugar varieties. In the Free State, it occurs in substantial quantities in honey, fruits, and berries. As a polymer of anhydrodextrose units, it occurs in starch, cellulose, and glycogen. Sucrose is a disaccharide of dextrose and fructose. Commercial production of dextrose by hydrolysis of starch yields white crystalline sugars that are either anhydrous (C6H12O6) or hydrated (C6H12O6H2O). Dextrose hydrate with its one molecule of water of crystallization per molecule of sugar, separates from concentrated solutions at <50°C. Anhydrous D-glucose does not contain water of crystallization and separates at 50-115°C. Another anhydrous form, B-D-glucose separates, if crystallization is carried out at temperatures >110-115°C. • Dextrose solution is used during post-operative period when sodium extraction is reduced. • Dextrose solution with concentration of 10-15% is used as di-urietic for increase in urine flow. • Dextrose solution of 5% normal salmicis used for restarting fluid volume in circulation of an emergency as in accidents with raemdrrhage. • Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through analimucationfistuala. • Dextrose monohydrate is used as supplement to cow's milk in part of feeding. The increasing prevalence of chronic diseases is expected to drive the growth of the market. It has been forecasted that cancer will rapidly increase by approximately 70% in the next few decades. As per the World Cancer Research Fund International, stomach cancer is one of the top 5 cancers with 952,000 new cases diagnosed in 2012. These patients are ‘nil by mouth’ and have to rely on total parenteral nutrition (TPN) for survival. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Thus, due to demand it is best to invest in this project. Few Indian Major Players • Pfizer Healthcare India Pvt. Ltd. • Pfizer Ltd. • Pharmacia Healthcare Ltd. • Shree Krishna Keshav Laboratories Ltd. • Vikrant Pharmaceuticals Ltd. • Wockhardt Health Care Ltd.
Plant capacity: Dextrose Saline 500 ml Size:15,000 Bottles Per Day Dextrose Saline 1000 ml Size:15,000 Bottles Per DayPlant & machinery: 1148 Lakhs
Working capital: -T.C.I: Cost of Project:1542 Lakhs
Return: 25.00%Break even: 44.00%
Add to Inquiry Add to Inquiry Basket

Business & Investment Opportunity in Manufacturing of Dextrose Saline. Lucrative Industry of I.V. Fluids Pharmaceutical Sector.

An intravenous sugar solution is also known as a dextrose solution. It's a dextrose and water mixture. Dextrose is a sugar that is used as a sweetener. As a result, the solution is made up of sugar. Since it is given through a vein or veins, it is called intravenous. 5 Dextrose is a 5 percent dextrose solution in which 5 g dextrose is dissolved in 100 mL of water. As a result, the percentage reflects the sugar solution's power. Dextrose saline is a solution that contains 5% dextrose, sodium chloride, and water. Dextrose 5 in.9 Sodium Chloride is a prescription drug that is used to treat hypoglycemia symptoms. Related Project:- DEXTROSE SALINE Dextrose 5 in.9 Sodium Chloride may be used on its own or in combination with other drugs. Dextrose 5 in.9 Sodium Chloride belongs to the Glucose-Elevating Agents; Metabolic and Endocrine, Other class of drugs. Dextrose is a carbohydrate, which is a nutrient found in most foods. Dextrose-based solutions include calories and can be supplied intravenously along with amino acids and fats. Absolute parenteral nutrition (TPN) is a method of providing nutrition to people who are unable to consume or obtain carbohydrates, amino acids, or fats through their digestive system. Dextrose is a calorie and energy-rich food. Dextrose is easily absorbed, aids in the reduction of nitrogen and protein losses, promotes glycogen deposition, and aids in the prevention of ketosis. Uses of Dextrose Saline: Dextrose is used to make a variety of intravenous (IV) formulations and mixtures that can only be obtained from a pharmacy or medical facility. Dextrose is also available over the counter in the form of an oral gel or an oral tablet from pharmacies. Each concentration of dextrose has its own set of applications. When anyone has a very low blood sugar reading, higher concentrations are usually used as a "rescue" dose. For hydration and nutrition, dextrose saline solution is used as a source of water, electrolytes, and calories. The following diseases, disorders, and symptoms are treated, regulated, prevented, and improved with Dextrose Saline Solution: Related Videos:- Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs • Blood and fluid loss • Treatment of insulin hypoglycemia • Intravenous infusion as carbohydrate source • Low sodium levels • Low potassium levels • Low magnesium levels • Low calcium levels Market Outlook: In clinical medicine, intravenous solutions are often used to replace and maintain body fluids. They are given to people who have lost body fluids due to dehydration or other medical conditions. Intravenous solutions are injected directly into the veins to offer immediate relief to those receiving care. Diarrhea is the world's second leading cause of death, affecting nearly 1.7 billion people, according to the World Health Organization (WHO). Market Research: - Market Research Report Every year, it kills 525,000 people. 9 percent regular saline, lactated ringers, 5 percent dextrose in water, and others make up the global intravenous solution market. The global intravenous solution market can be divided into three types of distribution channels: hospital pharmacies, drug stores, and specialty pharmacies. Regulatory and consistency criteria, on the other hand, add to the market's cost and uncertainty. Despite being marketed at reasonably low rates, intravenous fluids are regulated as medicinal products and must meet many of the capital expenditure standards of sterile injectable drugs, limiting market development. Covid-19 Impact on IV Fluids: The worldwide COVID-19 pandemic has drawn the world's attention to critical care as a specialty. There are currently no proven therapies for COVID-19, despite the publication of many trials and case series extolling the virtues of various agents. As is often the case, good intensive care practice is built on a solid understanding of physiology and a mastery of the fundamentals. Books: - BOOKS & DATABASES The need for strict separation of large numbers of patients due to the COVID-disease pandemic has made protecting the Rights of IV drug administration: Patient, prescription, dosage, path, pacing, and documentation are all becoming more difficult to manage. According to World Health Organization guidelines, patients with COVID-19 in respiratory failure should be treated with intravenous fluids with caution, particularly in settings where mechanical ventilation is limited. The basis for fluid control in critical care is the general principles of fluid therapy management Covid-19. Key Players: 1. Amanta Healthcare Ltd. 2. Baxter Pharmaceuticals India Pvt. Ltd. 3. Bayer Pharmaceuticals Pvt. Ltd. 4. Denis Chem Lab Ltd. 5. Meridian Enterprises Pvt. Ltd. 6. Pfizer Healthcare India Pvt. Ltd. 7. Pfizer Ltd. 8. Pharmacia Healthcare Ltd. 9. Shree Krishna Keshav Laboratories Ltd. For More Details: - https://bit.ly/3y81my0 #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #BusinessIdeas #StartupBusinessIdeas #BusinessOpportunity #ProductionBusiness #ManufacturingBusiness #DextroseSaline #PharmaceuticalIndustry #PharmaceuticalMarket #PharmaceuticalBusiness
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 23 of 24 | Total 236 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 23 24   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top